# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA619869 | F | Compound was evaluated for the potency to inhibit oxidation of arachidonic acid by human recombinant 5-Lipoxygenase using a spectrophotometric assay | 2 | assay format | Scientific Literature | |||
2. | ALA622829 | A | Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing | Rattus norvegicus | 4 | organism-based format | Scientific Literature | ||
3. | ALA874448 | A | Bioavailability in rat (Sprague-Dawley) (male) | Rattus norvegicus | 4 | organism-based format | Scientific Literature | ||
4. | ALA702328 | F | Compound was evaluated for production of leukotriene B4 in human whole blood (HWB) activated with ionophore A-23187. | Homo sapiens | 11 | organism-based format | Scientific Literature | ||
5. | ALA878772 | F | Compound was evaluated for production of leukotriene B4 in Ca+2 -ionophore -activated human polymorphonuclear (HPMN) leukocytes. | Homo sapiens | 12 | organism-based format | Scientific Literature | ||
6. | ALA1073576 | B | Inhibition of potato tuber 5LOX by polarographic method | Solanum tuberosum | 83 | assay format | Scientific Literature | ||
7. | ALA5247062 | A | Oral bioavailability in rat | Rattus norvegicus | 16 | organism-based format | Scientific Literature | ||
8. | ALA5247076 | F | Inhibition of Leukotriene B4 production in human whole blood | Homo sapiens | 6 | organism-based format | Scientific Literature | ||
9. | ALA5247078 | A | Cmax in rat plasma at 20 mg/kg, po | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
10. | ALA5247080 | B | Inhibition of human 5-LO expressed in Sf9 cells by spectrophotometric assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
11. | ALA5247081 | F | Inhibition of Leukotriene B4 production in human blood Polymorphonuclear neutrophil cells | Homo sapiens | 6 | tissue-based format | Scientific Literature |